NeuroThera Labs Inc.
Research NeuroThera Labs Inc. (NTLX) on Bullrun: market cap CAD 60.39M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNTLX
- ExchangeV
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencyCAD
- Market capCAD 60.39M
- Financial periodQ3 2025
- RevenueUSD 0
- Net income-USD 12.57K
- Free cash flow-USD 19.17K
Valuation Snapshot
latest market cap is CAD 60.39M.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-03 | CAD 60.39M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CAD.
About NeuroThera Labs Inc.
Neurothera Labs Inc. engages in the development of a portfolio of drugs based on cannabinoid molecules. The company develops programs based on tetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol for the treatment of Tourette syndrome, Alzheimer's disease and agitation, autism spectrum disorder, and status epilepticus. It also focuses on e-commerce operations, which sells hemp-based products. Neurothera Labs Inc. was formerly known as Miza III Ventures Inc. The company is based in Newark, Delaware.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is NeuroThera Labs Inc.'s market cap?
NeuroThera Labs Inc.'s market capitalization is CAD 60.39M.
What does NeuroThera Labs Inc. do?
Neurothera Labs Inc. engages in the development of a portfolio of drugs based on cannabinoid molecules. The company develops programs based on tetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol for the treatment of Tourette syndrome, Alzheimer's disease and agitation, autism spectrum disorder, and status epilepticus. It also focuses on e-commerce operations, which sells hemp-based products. Neurothera Labs Inc. was formerly known as Miza III Ventures Inc. The company is based in Newark, Delaware. Neurothera Labs Inc. is a subsidiary of SciSparc Ltd.